Individuals with common diseases but with a low polygenic risk score could be prioritized for rare variant screening

被引:43
|
作者
Lu, Tianyuan [1 ,2 ]
Zhou, Sirui [1 ]
Wu, Haoyu [1 ,3 ]
Forgetta, Vincenzo [1 ]
Greenwood, Celia M. T. [1 ,3 ,4 ,5 ]
Richards, J. Brent [1 ,3 ,4 ,6 ]
机构
[1] Jewish Gen Hosp, Ctr Clin Epidemiol, Lady Davis Inst Med Res, Montreal, PQ, Canada
[2] McGill Univ, Quantitat Life Sci Program, Montreal, PQ, Canada
[3] McGffl Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada
[4] McGffl Univ, Dept Human Genet, Montreal, PQ, Canada
[5] McGill Univ, Gerald Bronfman Dept Oncol, Montreal, PQ, Canada
[6] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England
基金
加拿大健康研究院;
关键词
rare variants; polygenic risk scores; exome sequencing; patient prioritization; risk stratification; BREAST-CANCER; BIOBANK; PREDICTION; MUTATIONS; DISCOVERY; DIAGNOSIS; GENOME;
D O I
10.1038/s41436-020-01007-7
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose Identifying rare genetic causes of common diseases can improve diagnostic and treatment strategies, but incurs high costs. We tested whether individuals with common disease and low polygenic risk score (PRS) for that disease generated from less expensive genome-wide genotyping data are more likely to carry rare pathogenic variants. Methods We identified patients with one of five common complex diseases among 44,550 individuals who underwent exome sequencing in the UK Biobank. We derived PRS for these five diseases, and identified pathogenic rare variant heterozygotes. We tested whether individuals with disease and low PRS were more likely to carry rare pathogenic variants. Results While rare pathogenic variants conferred, at most, 5.18-fold (95% confidence interval [CI]: 2.32-10.13) increased odds of disease, a standard deviation increase in PRS, at most, increased the odds of disease by 5.25-fold (95% CI: 5.06-5.45). Among diseased patients, a standard deviation decrease in the PRS was associated with, at most, 2.82-fold (95% CI: 1.14-7.46) increased odds of identifying rare variant heterozygotes. Conclusion Rare pathogenic variants were more prevalent among affected patients with a low PRS. Therefore, prioritizing individuals for sequencing who have disease but low PRS may increase the yield of sequencing studies to identify rare variant heterozygotes.
引用
收藏
页码:508 / 515
页数:8
相关论文
共 50 条
  • [41] Polygenic risk score prediction of multiple sclerosis in individuals of South Asian ancestry
    Breedon, Joshua R.
    Marshall, Charles R.
    Giovannoni, Gavin
    van Heel, David A.
    Dobson, Ruth
    Jacobs, Benjamin M.
    BRAIN COMMUNICATIONS, 2023, 5 (02)
  • [42] A polygenic risk score for nasopharyngeal carcinoma shows potential for risk stratification and personalized screening
    Yong-Qiao He
    Tong-Min Wang
    Mingfang Ji
    Zhi-Ming Mai
    Minzhong Tang
    Ruozheng Wang
    Yifeng Zhou
    Yuming Zheng
    Ruowen Xiao
    Dawei Yang
    Ziyi Wu
    Changmi Deng
    Jiangbo Zhang
    Wenqiong Xue
    Siqi Dong
    Jiyun Zhan
    Yonglin Cai
    Fugui Li
    Biaohua Wu
    Ying Liao
    Ting Zhou
    Meiqi Zheng
    Yijing Jia
    Danhua Li
    Lianjing Cao
    Leilei Yuan
    Wenli Zhang
    Luting Luo
    Xiating Tong
    Yanxia Wu
    Xizhao Li
    Peifen Zhang
    Xiaohui Zheng
    Shaodan Zhang
    Yezhu Hu
    Weiling Qin
    Bisen Deng
    Xuejun Liang
    Peiwen Fan
    Yaning Feng
    Jia Song
    Shang-Hang Xie
    Ellen T. Chang
    Zhe Zhang
    Guangwu Huang
    Miao Xu
    Lin Feng
    Guangfu Jin
    Jinxin Bei
    Sumei Cao
    Nature Communications, 13
  • [43] Development of a polygenic risk score to improve screening for fracture risk: A genetic risk prediction study
    Forgetta, Vincenzo
    Keller-Baruch, Julyan
    Forest, Marie
    Durand, Audrey
    Bhatnagar, Sahir
    Kemp, John P.
    Nethander, Maria
    Evans, Daniel
    Morris, John A.
    Kiel, Douglas P.
    Rivadeneira, Fernando
    Johansson, Helena
    Harvey, Nicholas C.
    Mellstrom, Dan
    Karlsson, Magnus
    Cooper, Cyrus
    Evans, David M.
    Clarke, Robert
    Kanis, John A.
    Orwoll, Eric
    McCloskey, Eugene, V
    Ohlsson, Claes
    Pineau, Joelle
    Leslie, William D.
    Greenwood, Celia M. T.
    Richards, J. Brent
    PLOS MEDICINE, 2020, 17 (07)
  • [44] A polygenic risk score for nasopharyngeal carcinoma shows potential for risk stratification and personalized screening
    He, Yong-Qiao
    Wang, Tong-Min
    Ji, Mingfang
    Mai, Zhi-Ming
    Tang, Minzhong
    Wang, Ruozheng
    Zhou, Yifeng
    Zheng, Yuming
    Xiao, Ruowen
    Yang, Dawei
    Wu, Ziyi
    Deng, Changmi
    Zhang, Jiangbo
    Xue, Wenqiong
    Dong, Siqi
    Zhan, Jiyun
    Cai, Yonglin
    Li, Fugui
    Wu, Biaohua
    Liao, Ying
    Zhou, Ting
    Zheng, Meiqi
    Jia, Yijing
    Li, Danhua
    Cao, Lianjing
    Yuan, Leilei
    Zhang, Wenli
    Luo, Luting
    Tong, Xiating
    Wu, Yanxia
    Li, Xizhao
    Zhang, Peifen
    Zheng, Xiaohui
    Zhang, Shaodan
    Hu, Yezhu
    Qin, Weiling
    Deng, Bisen
    Liang, Xuejun
    Fan, Peiwen
    Feng, Yaning
    Song, Jia
    Xie, Shang-Hang
    Chang, Ellen T.
    Zhang, Zhe
    Huang, Guangwu
    Xu, Miao
    Feng, Lin
    Jin, Guangfu
    Bei, Jinxin
    Cao, Sumei
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [45] Economic evaluation of using polygenic risk score to guide risk screening and interventions for the prevention of type 2 diabetes in individuals with high overall baseline risk
    Martikainen, Janne
    Lehtimaki, Aku-Ville
    Jalkanen, Kari
    Lavikainen, Piia
    Paajanen, Teemu
    Marjonen, Heidi
    Kristiansson, Kati
    Lindstrom, Jaana
    Perola, Markus
    FRONTIERS IN GENETICS, 2022, 13
  • [46] Blood Pressure Polygenic Risk Score Stratifies Individuals With High Risk Of Hypertension In Different Ancestries
    Teixeira, Samantha K.
    Souza, Vinicius
    Horta, Bernardo
    Pereira, Alexandre
    Krieger, Jose E.
    HYPERTENSION, 2022, 79
  • [47] Canalization of the Polygenic Risk for Common Diseases and Traits in the UK Biobank Cohort
    Nagpal, Sini
    Tandon, Raghav
    Gibson, Greg
    MOLECULAR BIOLOGY AND EVOLUTION, 2022, 39 (04)
  • [48] Using low-coverage non-invasive prenatal screening data for polygenic risk score calculation
    Becelaere, Sara
    Biagini, Simone Andrea
    Molinaro, Ludovica
    Cleynen, Isabelle
    Kivisild, Toomas
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1305 - 1306
  • [49] Correction: Polygenic risk for triglyceride levels in the presence of a high impact rare variant
    Shengjie Ying
    Tracy Heung
    Bhooma Thiruvahindrapuram
    Worrawat Engchuan
    Yue Yin
    Christina Blagojevic
    Zhaolei Zhang
    Robert A. Hegele
    Ryan K. C. Yuen
    Anne S. Bassett
    BMC Medical Genomics, 16 (1)
  • [50] Polygenic Risk Score of Common Genetic Variants for NSAIDS Hypersensitivity Prediction in Vietnamese
    Dinh Nguyen
    Trang Tran Thi Ha
    Mai Tran Hoang
    Nam Nguyen Le
    Nam Nguyen Ngoc
    Tien Pham Minh
    Quang Vu Thanh
    Anh Nguyen Quynh
    Mai Vu Thi
    Yen Pham Thi Hai
    Thang Nguyen Van
    Lan Phan Quynh
    Nguyet Nguyen Thi Minh
    Oanh Hoang Thi
    Thuy Can Thi Thu
    Anh Duong Thuy
    Nguyet Nguyen Nhu
    Hang Vu Thi
    Sheryl Nunen Van
    Timothy Craig John
    Nam Vo Sy
    Hieu Chu Chi
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB157 - AB157